MedPath

The effect of fish-oil supplementation on pregnancy outcomes in mother and infant

Not Applicable
Conditions
Condition 1: Pregnancy, childbirth and the puerperium. Condition 2: Pregnancy, childbirth and the puerperium. Condition 3: Pregnancy, childbirth and the puerperium. Condition 4: Pregnancy, childbirth and the puerperium. Condition 5: Pregnancy, childbirth and the puerperium. Condition 6: Pregnancy, childbirth and the puerperium. Condition 7: Certain conditions originating in the perinatal period. Condition 8: Certain conditions originating in the perinatal period.
Gestational [pregnancy-induced] hypertension with significant proteinuria
Diabetes mellitus in pregnancy, unspecified
Preterm labour and delivery
Single delivery by caesarean section
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
Pregnancy-related condition, unspecified
Fetus and newborn affected by maternal nutritional disorders
Disorders related to short gestation and low birth weight, not elsewhere classified
Registration Number
IRCT2013100914957N1
Lead Sponsor
ational Public-Health Management Center (NPMC)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
150
Inclusion Criteria

Healthy pregnant women in 16-20 weeks of pregnancy; Aged 18-35 years; 5th pregnancy or less; Singleton pregnancy; No history of infertility and premature birth; Not having history of depression or postpartum depression; Edinburgh depression score less than 23; Absence of known placenta previa or cerclage in this pregnancy; No adverse event occurred 6 months before the study
Exclusion criteria: Smoking or drugs using ;consumption of more than two servings fish per week; Having bleeding disorders or taking anticoagulants; BMI more than 30; participating in another study; Wanting to change living area in the next 6 months; No access to call phone; Being illiterate or unable to answer questions; History of sensitivity to fish oil or other fish products; sensitivity to gelatin; participation in other intervention study; Not willingness to participate; known underlying disease including heart, kidney, stomach, lung, thyroid or autoimmune diseases, diabetes, impaired glucose tolerance in pregnancy, epilepsy, essential hypertension,hyperlipidemia

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postpartum Depression. Timepoint: 6-8 weeks after childbirth. Method of measurement: Edinburgh Depression Scale.;Newborn Weight. Timepoint: Childbirth. Method of measurement: By means of newborns scale into gram.;Infant Neurodevelopment. Timepoint: 4 and 6 month. Method of measurement: ASQ Questionnare.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath